Ophthalmic cancers, though rare, present significant challenges in both diagnosis and treatment. These malignancies can affect various parts of the eye, including the retina, iris, and surrounding tissues. Research in this field focuses on improving early detection methods such as advanced imaging techniques and genetic screening to identify high-risk individuals. Additionally, there's a growing emphasis on developing targeted therapies tailored to the specific genetic mutations driving these cancers. Collaborative efforts between ophthalmologists, oncologists, and researchers aim to unravel the intricate biology of these tumors and devise more effective treatment strategies, ultimately improving outcomes and quality of life for patients with ophthalmic cancers.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States